Healthcare
DaVita Inc.(DVA)
Live Price
Offline$207.91
-1.27% today
1Y Change
+48.89%
Window
Jun 25, 2025 โ Jun 16, 2026
- Market Cap
- $10.36B
- Revenue Growth
- +6.5%
- EPS Growth
- -11.8%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 25, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
DaVita Inc. (DVA) is a Healthcare stock with a market cap of $10.36B and listed on NYSE. The stock last traded around $207.91 and up 48.9% across the available one-year price window (Jun 25, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of +6.5%, EPS growth of -11.8%, a dividend yield of 0.0%. What stands out right now is revenue +6.5%, EPS -11.8%, free cash flow -10.6% with operating margin 15.0% and ROIC 11.0%. Valuation is more restrained than many high-expectation growth names at P/E 15.7 and price/sales 0.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines DVA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+6.5% vs +7.6% peer median
Operating Margin
Below sector median
+15.0% vs +19.4% peer median
P/E
Below sector median
15.7 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 11, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +6.5% and EPS is at -11.8%, with operating margin around 15.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +6.6% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 11, 2026 | โ | +0.8% | +0.3% | -0.4% |
2026 Feb 2, 2026 | +4.9% | +21.2% | +23.8% | +36.9% |
2025 Oct 29, 2025 | -20.8% | -6.2% | -4.3% | -5.1% |
Benchmark Edge
DVA vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
DVA
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
DVA Max Drawdown
-31.36%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for DVA and SPY.
Company Overview
DaVita Inc.
New York Stock Exchange
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
- Leadership
- Javier J. Rodriguez
- IPO Date
- Oct 31, 1995
- Employees
- 76.0k
- Street Address
- 2000 16th Street
- Mailing
- Denver, CO, 80202
- Region
- Denver, CO, US
- Reporting Currency
- USD
- Investor Line
- 720 631 2100
- Last Updated
- Apr 28, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 15.7
- EV/EBITDA
- 9.0
- Price/Sales
- 0.7
- Price/Book
- โ
Growth
- Revenue
- +6.5%
- EPS
- -11.8%
- Free Cash Flow
- -10.6%
Profitability
- Gross Margin
- 23.3%
- Operating Margin
- 15.0%
- Net Margin
- 5.6%
- ROE
- -133.1%
- ROIC
- 11.0%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 1.42
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.